Anti-TNF agents and potential effects on male fertility: are men being counseled?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2490
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Anti-TNF agents and potential effects on male fertility: are men being counseled? ; volume:20 ; number:1 ; day:27 ; month:7 ; year:2020 ; pages:1-6 ; date:12.2020
BMC urology ; 20, Heft 1 (27.7.2020), 1-6, 12.2020
- Creator
-
Cooley, Lauren Folgosa
Wren, James
Keeter, Mary Kate
Lam, Isaac
Bennett, Nelson
Brannigan, Robert E.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12894-020-00658-7
- URN
-
urn:nbn:de:101:1-2020092021554893100069
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
2025-08-14T11:03:17+0200
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cooley, Lauren Folgosa
- Wren, James
- Keeter, Mary Kate
- Lam, Isaac
- Bennett, Nelson
- Brannigan, Robert E.
- SpringerLink (Online service)
Other Objects (12)
Monitoring of anti-TNF biological treatments
Impact of anti-TNF agents in postoperative complications in Crohn's disease: a review
Stopping Anti-TNF in CD Remitters: Cons
Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease – A Case Series
Anti-TNF, a magic bullet in cancer immunotherapy?
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates
Predictors of response and anti-TNF drugs comparative efficacy
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
Monitoring of anti-TNF biological treatments
Impact of anti-TNF agents in postoperative complications in Crohn's disease: a review
Stopping Anti-TNF in CD Remitters: Cons
Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease – A Case Series
Anti-TNF, a magic bullet in cancer immunotherapy?
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates
Predictors of response and anti-TNF drugs comparative efficacy
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy
The immunogenicity to the first anti-TNF therapy determines the outcome of switching to a second anti-TNF therapy in spondyloarthritis patients
Monitoring of anti-TNF biological treatments
Impact of anti-TNF agents in postoperative complications in Crohn's disease: a review
Stopping Anti-TNF in CD Remitters: Cons
Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents
Development of anti-TNF antibody-gold nanoparticles (anti-TNF-AuNPs)
Management of Uveitis Patients on Anti-TNF Agents Who Develop Demyelinating Disease – A Case Series
Anti-TNF, a magic bullet in cancer immunotherapy?
Combination of subtherapeutic anti-TNF dose with dasatinib restores clinical and molecular arthritogenic profiles better than standard anti-TNF treatment
Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates
Predictors of response and anti-TNF drugs comparative efficacy
Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy